Press Releases

AdvaMed Congratulates Phil Agress on Foreign Minister’s Commendation from Japan 

WASHINGTON, D.C.—AdvaMed today congratulated Phil Agress, former senior vice president of Global Strategy and Analysis, on receiving the Foreign Minister’s Commendation from the Government of Japan for his outstanding contributions to promoting economic relations between Japan and the United States. Japan’s Ambassador to the United States, the Honorable Shigeo Yamada, hosted the award presentation. 

Agress served at AdvaMed from 2004 until he retired in 2025. As the Embassy of Japan noted in announcing the honor, his contributions included convening policy dialogues involving medtech companies from both countries, leading the development of policy recommendations to promote bilateral cooperation in health care, and helping Japan better understand the U.S. regulatory system.  

“Phil spent two decades building relationships between our industry and our partners in Japan. This honor is well-deserved,” said Scott Whitaker, AdvaMed president and CEO. “He brought policymakers, researchers, and industry together around a shared goal: delivering innovative medtech to the patients who need it. On behalf of AdvaMed, congratulations and thank you to Phil. The foundation he set will serve medtech innovators and patients for years to come.” 

“Phil’s work strengthened the partnership between the U.S. and Japanese medtech communities, and this recognition reflects the respect he earned on both sides of the Pacific,” said Ashley Miller, AdvaMed executive vice president, Global Strategy and Analysis. “It was a privilege to work alongside him, and our Global team is committed to keeping the U.S.-Japan medtech partnership strong.” 

AdvaMed continues to engage Japan’s government, regulators, and industry on policies that support the innovation ecosystem and patient access to medtech, including through the Ikigai Symposium it co-hosts in Tokyo with the Japan Medical Association. 

### 

Call to Action Heading…

Call to Action Description…